Market Tracker

04/24 6:05pm ET

Seattle Genetics Inc (NASDAQ:SGEN)

39.33
Data as of Apr 24
 -0.46 / -1.16%
Today’s Change
28.15
Today|||52-Week Range
55.99
-1.40%
Year-to-Date
No recent news for Seattle Genetics Inc.

Today’s Trading

Previous close39.79
Today’s open39.99
Day’s range37.71 - 40.16
Volume778,964
Average volume (3 months)1,180,355
Market cap$4.8B
Dividend yield--
Data as of 3:59pm ET, 04/24/2014

Growth & Valuation

Earnings growth (last year)-10.87%
Earnings growth (this year)-87.49%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+27.73%
P/E ratioNM
Price/Sales18.01
Price/Book20.97

Competitors

 Today’s
change
Today’s
% change
UTHRUnited Therapeutics ...-0.13-0.14%
TAROTaro Pharmaceutical ...+0.51+0.46%
QCORQuestcor Pharmaceuti...+2.23+2.79%
MDVNMedivation Inc-2.32-3.86%
Data as of 4:02pm ET, 04/24/2014

Financials

Next reporting dateMay 2, 2014
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$269.3M
Annual profit (last year)-$62.5M
Net profit margin-23.22%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer &
Secretary
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts